Thesis (M.P.H.)--University of Texas Health Science Center at Houston, School of Public Health, 2008. / Source: Masters Abstracts International, Volume: 46-05, page: 2671. Advisers: Stephanie L. Mc Fall; Maria E. Fernandez. Includes bibliographical references.

Thesis (M.Sc.)--Memorial University of Newfoundland, Faculty of Medicine, 1999. / Bibliography: leaves 118-138.

Made available in DSpace on 2015-07-22T20:49:36Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-10-28 / Em 2002, o Estado de Mato Grosso aderiu à segunda fase de intensificação Programa Nacional de Controle do Câncer do Colo do Útero (PNCCU) como medida de enfrentamento das altas taxas da doença e de morte por neoplasia cervical. Com o objetivo de analisar os principais resultados do PNCCU, foi feito um estudo em duas partes. A primeira parte teve como objetivo levantar o perfil da doença e a cobertura do exame rastreamento pelo PNCCU no Estado. Os objetivos da segunda parte foram: analisar o seguimento clínico da população rastreada, analisar as diferentes características evolutivas da doença associadas aos fatores sócio-demográficos e clínicos, bem como analisar o risco de óbito e a taxa de sobrevida estratificada pelas variáveis sócio-demográficas e clínicas das mulheres que apresentaram carcinoma invasivo. Na primeira parte, foi utilizado estudo do tipo transversal e na segunda parte, foi realizado um estudo de coorte. O período do estudo compreendeu de 2002 a 2007 e abrangeu todos os municípios do Estado de Mato Grosso. A população estudada na primeira fase do estudo correspondeu todas as mulheres que fizeram o exame de rastreamento no ano de 2002. Na segunda parte do estudo, a população correspondeu a uma amostra aleatória representativa das mulheres que apresentaram alterações citológicas na primeira fase do estudo, totalizando 323 mulheres. A fonte de dados utilizada foi o sistema de informação oficial de saúde, dentre eles o SISCOLO, SIM, APAC, além de dados oficiais da Secretaria Estadual de Saúde/MT (SES/MT), dados disponíveis no site do INCA e do DATASUS e prontuários clínicos. Para análise estatística dos dados foram utilizadas técnicas descritivas e inferenciais. Na parte descritiva foram utilizados tabelas, gráficos e medidas de posição e de dispersão. Para avaliar a o risco de adoecer por carcinoma cervical invasor foi utilizado regressão logística univariada e multivariada. Para analisar a taxa de sobrevida global foi utilizado o estimador de Kaplan-Meier e para analisar os fatores prognósticos, foi utilizado o modelo de riscos proporcionais de Cox. Dentre os principais resultados, destaca-se que no período estudado, Mato Grosso apresentou taxas de incidência elevadas, acima da média nacional. Os dados do seguimento clínico mostraram os diferentes desfechos, dentre eles, destaca-se que: entre as 323 mulheres, 18 (6,2%) foram a óbito tendo o câncer do colo do útero como causa básica da morte. Foi analisado o risco de a doença evoluir para o carcinoma invasor, segundo as variáveis sócio-demográficas e clínicas, sendo que as variáveis: faixa etária, estado civil, tabagismo, menarca e município foram as que apresentaram forte associação com a doença na fase invasora. Já na análise de sobrevivência, a taxa de sobrevida global em 60 meses, estimada pelo método de Kaplan-Meier, foi de 66,7%. No modelo final de risco proporcional de Cox, as variáveis com maior risco de óbito foi o estágio avançado da doença e a raça/cor. Estes dados levam a concluir que a doença no Estado de Mato Grosso tem uma determinação social muito grande, considerando a dificuldade de acesso aos serviços de saúde da população desfavorecida pelas condições raciais, sócio-econômicas, e chegam aos serviços com a doença em fase adiantada, quando a chance de sobrevivência é muito pequena. Conclui-se que para o efetivo combate a doença são necessárias políticas governamentais, como o PNCCU, que garantam a universalidade da assistência, principalmente da população desfavorecida socialmente. / In 2002, the State joined the second phase of intensification of the National Program for the Control of Cervical Cancer (PNCCU) as a measure to deal with the high rates of the disease and of death by cervical neoplasia. With the aim of analyzing the main PNCCU results, a two-stage study was carried out. The first phase aimed at presenting the disease profile and the coverage of the screening exam by the PNCCU in the State. The aims of the second phase were to analyze the clinical follow-up of the population that was screened, analyze the different evolutionary characteristics of the disease associated to socio-demographic and clinic factors, as well as analyze the factors associated to death risk and the stratified survival rate by the socio-demographic and clinical variables of women that presented invasive carcinoma. In the first part, the cross-sectional study was used and a cohort study was used in the second phase. The period of study was from 2002 to 2007 and comprised all the municipalities of the State of Mato Grosso. The population studied in the first phase of the study was all the women who had undergone the screening test in 2002. The population used in the second phase of the study was a representative random sample of those that presented cytological alterations in the first phase of the study, a total of 323 women. The source of data used was the official health information system, among them the SISCOLO, SIM, APAC, and also the official data of the State Health Department/MT (SES/MT), data available in the INCA and DATASUS sites and medical records. For the statistical analysis of the data, descriptive and inferential techniques were used. In the descriptive part, tables, graphics and position and dispersion measures were used. In order to evaluate the risk of being sick due to invasive cervical carcinoma, the univariate and multivariate logistic regression analysis was used. The Kaplan-Meier estimator was used to analyze the survival rate and to analyze the prognostic factors, the Cox proportional hazards model was used. Among the main results it is highlighted that in 2002, Mato Grosso presented high incidence rates, above the national average. The data of the clinical follow up showed the different clinical outcomes, among the 323 women, 18 (6,2%) died having as the basic cause of death the cervical cancer. The risk of the disease developing into the invasive carcinoma was analyzed according to the socio-demographic and clinical variables, and the variables: age group, marital status, smoking history, menopause and municipality were those that presented a strong association with the disease in the invasive phase. However, in the survival analysis, the global survival rate in 60 months, estimated by the Kaplan-Meier method, was of 66,7%. In the final Cox proportional hazards model, the variables with higher death risk was the advanced stage of the disease and the race/color. These data lead to a conclusion that the disease in the State of Mato Grosso has a very large social determination, considering the difficulties in the access to the health services by the population affected by racial, socio-economic conditions that arrive in the health services with the disease in an advanced stage, when the survival probability is very small. The conclusion is that for the effective fight against the disease governmental policies such as the PNCCU are necessary, and that the universality of the assistance be guaranteed, mainly to the socially disadvantaged population. / TEDE / BV UNIFESP: Teses e dissertações

Introdução: O câncer do colo do útero é uma das neoplasias malignas mais frequentes, particularmente nos países em desenvolvimento e, sobretudo nos grupos com maior vulnerabilidade social. As estimativas de incidência e mortalidade tendem para a redução, porém em ritmo lento. Vários são os fatores de risco identificados, no entanto, apresenta um dos mais altos potenciais de prevenção e cura. A estratégia utilizada para a detecção precoce é o exame de Papanicolaou. Inquéritos de base populacional representam oportunidades únicas para a obtenção de informações que possibilitam avanço no conhecimento das condições de vida e saúde da população e para a formulação e avaliação de políticas sociais de saúde. Objetivo: Analisar a realização do exame de Papanicolaou segundo variáveis socioeconômicas, demográficas, de estilo de vida, estado de saúde e o uso de serviços de saúde das mulheres com 20 anos ou mais de idade, residentes no município de São Paulo, Brasil. Métodos: Estudo transversal de base populacional, com dados obtidos através do Inquérito de Saúde no Município de São Paulo ISA Capital, 2008, em amostra composta por 1.236 mulheres com 20 anos ou mais. Considerou-se a prevalência do exame realizado nos últimos 3 anos que antecederam à entrevista. Para as análises estatísticas foi utilizado o módulo survey do programa Stata 10.0. O modelo de regressão de Poisson foi aplicado para verificar associações mais precisas da realização do exame com as variáveis estudadas. A confidencialidade foi garantida. Resultados: As associações estatisticamente significantes encontradas foram: idade (20 a 29 anos), ser casada ou ter companheiros, escolaridade (12 anos), tabagismo (exfumantes), mulheres que possuíam exame clínico das mamas e plano de saúde. O Sistema Único de Saúde foi responsável por 39,2 por cento dos exames de Papanicolaou realizados. O motivo referido para a não realização do exame mais frequente foi não era necessário/sou saudável. Discussão: Ao considerar a realização do exame conforme recomendada pelo Ministério da Saúde, seria esperada cobertura de Papanicolaou superior à observada. Em termos de condições socioeconômicas, as associações com renda e atividade remunerada não permaneceram no modelo final, sugerindo equidade social na realização do exame. Entretanto, os serviços de saúde devem criar estratégias que ampliem o acesso às populações mais vulneráveis proporcionando maior conhecimento e envolvimento da população na incorporação das práticas preventivas do câncer do colo do útero, oferecendo um atendimento de maior qualidade a todas as mulheres, sobretudo, as SUS dependentes. Considerações Finais: Para o êxito do programa de rastreamento, deve-se priorizar a capacitação dos profissionais de saúde, a qualidade dos exames, a garantia do seguimento e tratamento dos casos e o estabelecimento de intervenções mais humanizadas e equitativas na utilização dos serviços de saúde do SUS / Introduction: Cervical cancer is one of the most frequent malignancies, particularly in developing countries and especially in groups with higher social vulnerability. Estimates of incidence and mortality tend to decrease but at a slow pace. Several risk factors are identifies, however, shows one of the highest potential for prevent and cure. The strategy used for early detection is the Pap smear. Population-based surveys represent unique opportunities to obtain information to enable an advance in knowledge of living conditions and population health and for the formulation and evaluation of welfare policies. Objective: To analyze the performance of Pap smears according to socioeconomic variables, demographic, lifestyle, health status and use of health services for women aged 20 or older, residing in São Paulo, Brazil. Methods: Cross-sectional population-based data obtained from the Survey of Health in São Paulo - ISA Capital, 2008, in a sample of 1,236 women aged 20 years or more. We considered the prevalence of the examination in the last three years prior to the interview. For statistical analysis we used the survey module in Stata 10.0. The Poisson regression model was applied to assess associations more precise examination carried out with the variables. Confidentiality was guaranteed. Results: Statistically significant associations were found: age (20 to 29 years old), be married or have partners, education ( 12 years), smoking (former smokers), women who had a clinical breast exam and health plan. The Unified National Health System was responsible for 39,2 per cent of the reported Pap smears. The most frequent reported reason for not undergoing the test was \"not necessary / I\'m healthy.\" Discussion: When considering the test as recommended by the Ministry of Health, Pap smear coverage would be expected higher than that observed. In terms of socioeconomic conditions, the association with income and remunerated activity did not remain in the final model, suggesting an social equity in the exam. However, health services should develop strategies to increase access to vulnerable populations by providing greater knowledge and involvement of the population in the incorporation of preventive practices of cancer of the cervix, providing a higher quality care to all women, mainly the SUS dependent. Final considerations: For the success of the screening program, one should prioritize the training of health professionals, the quality of examinations, ensuring the monitoring and treatment of cases, and the establishment of more humane and equitable interventions at use of SUS´s health services

Cheung, Tak Hong. / "July 2011." / Thesis (M.D.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 166-199). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web.

INTRODUÇÃO: O câncer do colo uterino é a terceira neoplasia maligna que mais afeta as mulheres brasileiras e, quando não detectada precocemente, apresenta prognóstico reservado. O câncer do colo uterino é consequência da infecção pelo Papilomavírus humano (HPV). Pouco é conhecido sobre a influência dos genótipos do HPV na apresentação clínica e o seu impacto na taxa de sobrevida no câncer do colo uterino. Os objetivos do estudo foram identificar os genótipos de HPV no tecido tumoral da população atendida no Instituto do Câncer do Estado de São Paulo e associar os genótipos de HPV aos fatores de risco conhecidos para o câncer do colo uterino. MÉTODOS: Foram incluídas mulheres com diagnóstico de câncer do colo uterino atendidas no Instituto do Câncer do Estado de São Paulo (ICESP) entre maio de 2008 e junho de 2012. A análise do material tumoral parafinado confirmou histologicamente o diagnóstico de câncer do colo uterino. O DNA tumoral foi extraído de três fragmentos de 10?m de espessura do bloco de parafina de carcinoma do colo uterino e submetido ao ensaio clínico Onclarity (sistema automatizado da BD Viper LT) para detecção e genotipagem do HPV. Idade ao diagnóstico, estadiamento clínico, tipo histológico e tempo de sobrevida foram obtidos a partir de registros do prontuário até dezembro de 2015. RESULTADOS: Foram analisadas 414 pacientes. As frequências dos genótipos estudados foram HPV16 (54%) HPV18(9%), HPV33-­58 (6%), HPV45 (5%), HPV31 (3%), HPV39-­68-­ 35 (3%), HPV59-­56-­66(3%), HPV52 (2%) e HPVnegativo (14%). A idade da população estudada variou de 17 a 87 anos, com média etária de 50,8 (DP=13,8 anos). Os tipos histológicos foram carcinoma de células escamosas (75%), adenocarcinoma (21%) e outros tipos histológicos (4%). Conforme o estadiamento clínico adotado pela FIGO (2009), 35% foi classificado como 1A1, 1A2 e 1B1, 17% como 1B2 e 2A e 48% como 2B a 4B. O genótipo do HPV apresentou distribuição diferente quanto à idade ao diagnóstico, tipo histológico e estadiamento. A mediana do tempo de sobrevida global desta coorte de pacientes com câncer do colo uterino foi de 37 meses [12-­53 meses]. A sobrevida global acumulada em 5 anos após o diagnóstico de câncer do colo uterino foi de 55%. Ocorreram 119 (38%) óbitos no período e 133 (42%) recidivas subdivididas em três grupos: local (12%), regional (30%) e à distância (58%). Curvas de sobrevida de Kaplan-­Meier e estatística de Log-­rank demonstraram que os genótipos de HPV 16 e 18 (59%) não se relacionaram a um pior prognóstico em comparação com outros genótipos de HPV (41%) (P=0,17). Idade ao diagnóstico, estadiamento clínico, tipo histológico, invasão vascular, metástase linfonodal, tamanho do tumor e os genótipos HPV16, HPV18 e HPVoutros foram analisados individualmente em um modelo de regressão de Cox. O genótipo do HPV se associou a pior taxa de sobrevida global apenas quando detectado mais de um HPV no material tumoral analisado. CONCLUSÃO: Apesar das diferentes distribuições dos os genótipos do HPV quanto à idade ao diagnóstico, tipo histológico e estadiamento, o genótipo do HPV não se mostrou como fator prognóstico independente no câncer do colo uterino / INTRODUCTION: Uterine cervical cancer is the third most common malignant neoplasm affecting Brazilian women. Prognosis is poor when diagnosis is delayed. Cervical cancer is a consequence of human papillomavirus (HPV) infection. Little is known about the influence of HPV genotypes in Brazil and its impact on cancer survival rate The purpose of the present study were to identify HPV genotypes of tumoral tissue from the affected population and to examine the association between HPV genotype and traditional cervical cancer risk factors. METHODS: Women diagnosed with cervical cancer at the Cancer Institute of the State of São Paulo (ICESP) between May 2008 and June 2012 were included in the study. Tumor specimens were reviewed to confirm the diagnosis of cervical cancer. Tumor DNA was extracted from three 10?m-­thick paraffin block fragments of each subject. HPV genotype was detected using the Onclarity system (BD Viper LT automated system). Age at diagnosis, clinical staging, histological type and survival time were obtained from the hospital electronic data records until December 2015. RESULTS: 414 patients were analyzed. The HPV genotypes studied were HPV16 (54%) HPV18 (9%), HPV33-­58 (6%), HPV45 (5%), HPV31 (3%), HPV39-­68-­35 (3%), HPV59-­56-­ 66(3%), HPV52 (2%) and HPVnegative (14%). The age of the study population ranged from 17 to 87 years, mean age= 50.8 (SD=13.8 years). Histological types were classified as squamous cell carcinoma (75%), adenocarcinoma (21%) and other histological types (4%). According to the 2009 FIGO clinical staging, 35% were classified as 1A1, 1A2 and 1B1, 1B2 and 17% as 2A and 48% as 2B the 4B. HPV genotypes showed different distributions regarding age, histologic tumor types and clinical staging. The median overall survival time was 37 months [12-­53 months]. The cumulative overall survival at 5 years after diagnosis of cervical cancer was 55%. There were 119 (38%) deaths during the study period and 133 (42%) recurrences subdivided into three groups: local (12%), regional (30%) and distant (58%). Kaplan-­Meier survival curves and Log-­rank statistics showed that HPV 16/18 (59%) did not influence prognosis compared to other HPV subtypes (41%) (P=0.17). Age at diagnosis, clinical stage, histological type, vascular invasion, lymph node metastasis, tumor size and HPV16 genotypes, HPV18 and HPVothers were individually analyzed in a Cox regression model. HPV genotype was associated with poorer overall survival rate only when multiple HPV infection was detected in the tumoral specimen. CONCLUSION: Although HPV genotype showed different distribution regarding age at diagnosis, histological type and clinical staging, HPV genotype was not an independent prognostic factor of cervical cancer in the study population

INTRODUÇÃO: O câncer do colo uterino é a terceira neoplasia maligna que mais afeta as mulheres brasileiras e, quando não detectada precocemente, apresenta prognóstico reservado. O câncer do colo uterino é consequência da infecção pelo Papilomavírus humano (HPV). Pouco é conhecido sobre a influência dos genótipos do HPV na apresentação clínica e o seu impacto na taxa de sobrevida no câncer do colo uterino. Os objetivos do estudo foram identificar os genótipos de HPV no tecido tumoral da população atendida no Instituto do Câncer do Estado de São Paulo e associar os genótipos de HPV aos fatores de risco conhecidos para o câncer do colo uterino. MÉTODOS: Foram incluídas mulheres com diagnóstico de câncer do colo uterino atendidas no Instituto do Câncer do Estado de São Paulo (ICESP) entre maio de 2008 e junho de 2012. A análise do material tumoral parafinado confirmou histologicamente o diagnóstico de câncer do colo uterino. O DNA tumoral foi extraído de três fragmentos de 10?m de espessura do bloco de parafina de carcinoma do colo uterino e submetido ao ensaio clínico Onclarity (sistema automatizado da BD Viper LT) para detecção e genotipagem do HPV. Idade ao diagnóstico, estadiamento clínico, tipo histológico e tempo de sobrevida foram obtidos a partir de registros do prontuário até dezembro de 2015. RESULTADOS: Foram analisadas 414 pacientes. As frequências dos genótipos estudados foram HPV16 (54%) HPV18(9%), HPV33-­58 (6%), HPV45 (5%), HPV31 (3%), HPV39-­68-­ 35 (3%), HPV59-­56-­66(3%), HPV52 (2%) e HPVnegativo (14%). A idade da população estudada variou de 17 a 87 anos, com média etária de 50,8 (DP=13,8 anos). Os tipos histológicos foram carcinoma de células escamosas (75%), adenocarcinoma (21%) e outros tipos histológicos (4%). Conforme o estadiamento clínico adotado pela FIGO (2009), 35% foi classificado como 1A1, 1A2 e 1B1, 17% como 1B2 e 2A e 48% como 2B a 4B. O genótipo do HPV apresentou distribuição diferente quanto à idade ao diagnóstico, tipo histológico e estadiamento. A mediana do tempo de sobrevida global desta coorte de pacientes com câncer do colo uterino foi de 37 meses [12-­53 meses]. A sobrevida global acumulada em 5 anos após o diagnóstico de câncer do colo uterino foi de 55%. Ocorreram 119 (38%) óbitos no período e 133 (42%) recidivas subdivididas em três grupos: local (12%), regional (30%) e à distância (58%). Curvas de sobrevida de Kaplan-­Meier e estatística de Log-­rank demonstraram que os genótipos de HPV 16 e 18 (59%) não se relacionaram a um pior prognóstico em comparação com outros genótipos de HPV (41%) (P=0,17). Idade ao diagnóstico, estadiamento clínico, tipo histológico, invasão vascular, metástase linfonodal, tamanho do tumor e os genótipos HPV16, HPV18 e HPVoutros foram analisados individualmente em um modelo de regressão de Cox. O genótipo do HPV se associou a pior taxa de sobrevida global apenas quando detectado mais de um HPV no material tumoral analisado. CONCLUSÃO: Apesar das diferentes distribuições dos os genótipos do HPV quanto à idade ao diagnóstico, tipo histológico e estadiamento, o genótipo do HPV não se mostrou como fator prognóstico independente no câncer do colo uterino / INTRODUCTION: Uterine cervical cancer is the third most common malignant neoplasm affecting Brazilian women. Prognosis is poor when diagnosis is delayed. Cervical cancer is a consequence of human papillomavirus (HPV) infection. Little is known about the influence of HPV genotypes in Brazil and its impact on cancer survival rate The purpose of the present study were to identify HPV genotypes of tumoral tissue from the affected population and to examine the association between HPV genotype and traditional cervical cancer risk factors. METHODS: Women diagnosed with cervical cancer at the Cancer Institute of the State of São Paulo (ICESP) between May 2008 and June 2012 were included in the study. Tumor specimens were reviewed to confirm the diagnosis of cervical cancer. Tumor DNA was extracted from three 10?m-­thick paraffin block fragments of each subject. HPV genotype was detected using the Onclarity system (BD Viper LT automated system). Age at diagnosis, clinical staging, histological type and survival time were obtained from the hospital electronic data records until December 2015. RESULTS: 414 patients were analyzed. The HPV genotypes studied were HPV16 (54%) HPV18 (9%), HPV33-­58 (6%), HPV45 (5%), HPV31 (3%), HPV39-­68-­35 (3%), HPV59-­56-­ 66(3%), HPV52 (2%) and HPVnegative (14%). The age of the study population ranged from 17 to 87 years, mean age= 50.8 (SD=13.8 years). Histological types were classified as squamous cell carcinoma (75%), adenocarcinoma (21%) and other histological types (4%). According to the 2009 FIGO clinical staging, 35% were classified as 1A1, 1A2 and 1B1, 1B2 and 17% as 2A and 48% as 2B the 4B. HPV genotypes showed different distributions regarding age, histologic tumor types and clinical staging. The median overall survival time was 37 months [12-­53 months]. The cumulative overall survival at 5 years after diagnosis of cervical cancer was 55%. There were 119 (38%) deaths during the study period and 133 (42%) recurrences subdivided into three groups: local (12%), regional (30%) and distant (58%). Kaplan-­Meier survival curves and Log-­rank statistics showed that HPV 16/18 (59%) did not influence prognosis compared to other HPV subtypes (41%) (P=0.17). Age at diagnosis, clinical stage, histological type, vascular invasion, lymph node metastasis, tumor size and HPV16 genotypes, HPV18 and HPVothers were individually analyzed in a Cox regression model. HPV genotype was associated with poorer overall survival rate only when multiple HPV infection was detected in the tumoral specimen. CONCLUSION: Although HPV genotype showed different distribution regarding age at diagnosis, histological type and clinical staging, HPV genotype was not an independent prognostic factor of cervical cancer in the study population

Estudo transversal, descritivo e exploratório, com abordagem metodológica qualitativa, cujo objetivo foi identificar e avaliar a percepção da vulnerabilidade à doença, entre mulheres com diagnóstico avançado do câncer do colo do útero, tendo como referencial teórico, a vulnerabilidade, baseada no conceito proposto por Ayres et al. (2003). Os sujeitos do estudo foram doze mulheres que estavam em atendimento no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, para tratamento do câncer do colo do útero avançado, entre 08 de abril e 28 de maio de 2009. Os dados foram coletados por entrevistas. A análise dos dados se deu segundo os pressupostos da análise de conteúdo, proposta por Bardin (2006). Os resultados revelaram-se em 2 categorias centrais: Percebendo-se vulnerável e Enfrentando a doença e o tratamento. A vulnerabilidade se apresentou para as participantes deste estudo a partir do aparecimento dos primeiros sinais e sintomas da doença, crescendo à medida que o diagnóstico foi descoberto e o tratamento se fez necessário, trazendo dificuldades e sofrimento. Ao mesmo tempo, proporcionou a oportunidade de as mulheres encontrarem formas de enfrentamento e superação dos problemas, à medida do possível. Os componentes individual, social e programático da vulnerabilidade, contidos no conceito proposto por Ayres et al. (2003), mostraram-se nos fatores relacionados à cliente, aos profissionais, aos serviços, entre outros, e tornaram a mulher suscetível aos problemas e danos de sua saúde, relativos ao câncer cérvico-uterino, exacerbando sua vulnerabilidade à doença. Ficou clara a necessidade de se superar algumas deficiências no modelo de assistência e na humanização do atendimento, no grau de compromisso e na qualidade das instituições, dos recursos, do gerenciamento e do monitoramento dos programas de prevenção e detecção do câncer do colo do útero, nos diferentes níveis de atenção. / This cross-sectional, descriptive, exploratory and qualitative study aimed to identify and evaluate the perception of the vulnerability to the disease among women with delayed diagnosis of uterine cervical cancer. The theoretical framework used was the vulnerability, based in the concept proposed by Ayres et al. (2003). The subjects of the study were twelve women who were under follow-up at the Hospital das Clínicas of the University of São Paulo at Ribeirão Preto Medical School, for treatment of advanced uterine cervical cancer, between April 08th and May 28th 2009. Data were collected by interviews. The data analysis was done according to the presuppositions of content analysis, proposed by Bardin (2006). Two central categories emerged from the results: Perceiving yourself vulnerable and Facing the disease and the treatment. The vulnerability arose to the participants of this study through the emergence of the first signs and symptoms of the disease, increasing as the diagnosis was determined and treatment was needed, bringing difficulties and suffering. At the same time, women had the opportunity to find ways to face and overcome problems, to the extent possible. The individual, social and programmatic compounds of the vulnerability, included in the concept proposed by Ayres et al. (2003), were shown in the factors related to clients, professionals and services, among others, and made the women susceptible to the problems and damages of their health, related to the uterine cervical cancer, aggravating their vulnerability to the disease. The need to overcome some deficiencies in the model of care and in the humanization of care was evidenced, as well as in the level of commitment and in the quality of the institutions, resources, management, and monitoring of the programs of prevention and detection of uterine cervical cancer, in the different levels of care.

Luk, Chun Shui. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 174-189). / Abstract also in Chinese. / Declaration --- p.I / Acknowledgements --- p.II / Funding Support --- p.IV / Abstract of thesis entitled --- p.V / 論文摘要 --- p.VII / Abbreviations --- p.IX / Table of Contents --- p.XIII / List of Figures --- p.XVIII / List of Tables --- p.XX / List of Appendix --- p.XXI / Chapter Chapter One - --- Literature Review --- p.1 / Chapter 1.1 --- History of Knowledge on Human Papillomavirus --- p.1 / Chapter 1.2 --- Virology of Human Papillomavirus --- p.2 / Chapter 1.2.1 --- Taxonomic Classification of Human Papillomavirus --- p.2 / Chapter 1.2.2 --- Morphology of Human Papillomavirus --- p.3 / Chapter 1.2.3 --- The Viral Genome --- p.3 / Chapter 1.2.4 --- The Viral Gene Products --- p.5 / Chapter 1.2.4.1 --- E1 and E2 Proteins --- p.5 / Chapter 1.2.4.2 --- E4 Protein --- p.6 / Chapter 1.2.4.3 --- "E5，E6, E7 Proteins" --- p.7 / Chapter 1.2.4.4 --- L1 and L2 Proteins --- p.8 / Chapter 1.3 --- Evolution of Human Papillomavirus --- p.9 / Chapter 1.3.1 --- Rates of Evolution --- p.11 / Chapter 1.3.2 --- Co-evolution Between Human Papillomavirus and Human --- p.11 / Chapter 1.4 --- Human Papillomavirus Infection and Disease --- p.13 / Chapter 1.4.1 --- Human Papillomavirus and Cervical Cancer --- p.13 / Chapter 1.4.1.1 --- Disease Burden of Cervical Cancer --- p.13 / Chapter 1.4.1.2 --- Epidemiology of Cervical Cancer --- p.14 / Chapter 1.4.1.3 --- Distribution of HPV types in Cervical Precancerous Lesions --- p.14 / Chapter 1.4.2 --- Human Papillomavirus and Non-cervical Diseases --- p.15 / Chapter 1.5 --- Human Papillomavirus Type 58 --- p.15 / Chapter 1.5.1 --- Biology of Human Papillomavirus Type 58 --- p.15 / Chapter 1.5.2 --- Epidemiology of Human Papillomavirus Type 58 Infections --- p.16 / Chapter Chapter Two - --- Background and Objectives of Study --- p.17 / Chapter 2.1 --- Background of study --- p.17 / Chapter 2.1.1 --- The Need for Research on HPV58 --- p.17 / Chapter 2.1.2 --- Intratypic Classification System for HPV --- p.17 / Chapter 2.2 --- Implication and Impact of Study --- p.19 / Chapter 2.2.1 --- Implication on HPV Virology --- p.19 / Chapter 2.2.2 --- HPV58 Classification --- p.19 / Chapter 2.2.3 --- Improvement on in the Detection of HPV58 --- p.20 / Chapter 2.2.4 --- Implication on Vaccine Development --- p.20 / Chapter 2.3 --- Objectives of Study --- p.21 / Chapter 2.3.1 --- To Generate a Database for Intratypic Variation of Different Gene Regions of HPV58 --- p.21 / Chapter 2.3.2 --- To Study the Variability of Seven Gene Regions of HPV58 --- p.21 / Chapter 2.3.3 --- To Study the Geographical Distribution of HPV58 Variants --- p.22 / Chapter 2.3.4 --- To Study the Phylogeny of HPV58 --- p.22 / Chapter 2.3.5 --- To Develop an Intratypic Classification System for HPV58 --- p.22 / Chapter 2.3.6 --- To Predict the Effectiveness of Commonly Used Primers on the Detection of HPV58 --- p.22 / Chapter Chapter Three - --- Materials and Methods --- p.24 / Chapter 3.1 --- Overall Study Design --- p.24 / Chapter 3.2 --- Study Population --- p.25 / Chapter 3.3 --- Sample Processing and Storage --- p.25 / Chapter 3.4 --- Primer Design --- p.26 / Chapter 3.5 --- Specimen Quality Assessment and Sample Selection --- p.30 / Chapter 3.6 --- Amplification of Gene Region --- p.30 / Chapter 3.7 --- Agarose Gel Electrophoresis --- p.34 / Chapter 3.8 --- Sequencing Reaction --- p.34 / Chapter 3.8.1 --- Purification of PCR Product --- p.34 / Chapter 3.8.2 --- Sequencing Reaction --- p.35 / Chapter 3.8.3 --- Purification of Fluorescence-labelled Product --- p.35 / Chapter 3.8.4 --- Sequence Identification --- p.35 / Chapter 3.9 --- Sequence Analysis --- p.36 / Chapter 3.9.1 --- Sequence Editing --- p.36 / Chapter 3.9.2 --- Criteria for Confirming the identity of HPV58 --- p.36 / Chapter 3.9.3 --- Identification of Variants --- p.38 / Chapter 3.9.4 --- Identification of Conserved and Variable Regions --- p.39 / Chapter 3.9.5 --- Phylogenetic Analysis --- p.40 / Chapter 3.9.5.1 --- Construction of Maximum Likelihood Tree --- p.40 / Chapter 3.9.5.2 --- Bootstrap Analysis --- p.41 / Chapter 3.9.5.3 --- Bayesian Phylogenetic Analysis --- p.42 / Chapter 3.9.5.4 --- Non-synonymous to Synonymous Substitution Rate Ratio (dN/dS) --- p.42 / Chapter 3.9.6 --- Evaluation of Performance of Commonly Used Primers --- p.43 / Chapter Chapter Four - --- Results --- p.44 / Chapter 4.1 --- Specimen Quality Assessment and HPV58 Confirmation --- p.44 / Chapter 4.2 --- HPV58 Genome Variability --- p.44 / Chapter 4.2.1 --- E6 Open Reading Frame --- p.45 / Chapter 4.2.2 --- E7 Open Reading Frame --- p.51 / Chapter 4.2.3 --- E2 Open Reading Frame --- p.56 / Chapter 4.2.4 --- E4 Open Reading Frame --- p.61 / Chapter 4.2.5 --- E5 Open Reading Frame --- p.66 / Chapter 4.2.6 --- L1 Open Reading Frame --- p.71 / Chapter 4.2.7 --- Long Control Region --- p.88 / Chapter 4.2.8 --- Whole HPV genome --- p.94 / Chapter 4.3 --- Evaluation of Commonly Used Primers --- p.99 / Chapter 4.3.1 --- PGMY09/11 Primers --- p.99 / Chapter 4.3.2 --- MY09/11 Primers --- p.99 / Chapter 4.3.3 --- GP5+/6+ Primers --- p.100 / Chapter 4.3.4 --- SPF Primers --- p.100 / Chapter 4.3.5 --- L1F/L1R Primers --- p.101 / Chapter Chapter Five - --- Discussion --- p.111 / Chapter 5.1 --- Overall Variation of HPV58 Genome --- p.111 / Chapter 5.2 --- Variability of Each Gene Region --- p.114 / Chapter 5.2.1 --- E6 Open Reading Frame --- p.115 / Chapter 5.2.2 --- E7 Open Reading Frame --- p.116 / Chapter 5.2.3 --- E2 Open Reading Frame --- p.117 / Chapter 5.2.4 --- E4 Open Reading Frame --- p.118 / Chapter 5.2.5 --- E5 Open Reading Frame --- p.119 / Chapter 5.2.6 --- L1 Open Reading Frame --- p.120 / Chapter 5.2.7 --- Long Control Region --- p.121 / Chapter 5.3 --- Phylogenetics of HPV58 --- p.122 / Chapter 5.3.1 --- Natural Selection Pressure --- p.122 / Chapter 5.3.2 --- HPV58 Lineage Using the L1 Gene --- p.124 / Chapter 5.3.3 --- Methods for Lineage Identification --- p.125 / Chapter 5.3.4 --- Geographical Distribution of the Four Lineages --- p.126 / Chapter 5.3.5 --- Recombination --- p.127 / Chapter 5.4 --- Evaluation of Commonly Used Primers --- p.128 / Chapter 5.5 --- Limitations of the Current Study --- p.129 / Chapter 5.6 --- Future Studies --- p.130 / Appendix --- p.133 / References --- p.174

Die in der Bundesrepublik Deutschland übliche Therapie für das Zervixkarzinom der FIGO-Stadien IB-IIB ist die Wertheim-Meigs-Operation. Bei bestimmten Risikofaktoren wird häufig eine adjuvante Bestrahlung, gegebenenfalls eine postoperative Radioche-motherapie angeschlossen. Die Folge können zahlreiche Einschränkungen der gesund-heitsbezogenen Lebensqualität sein. Zur Verbesserung der postoperativen gesund-heitsbezogenen Lebensqualität wurde eine neue nervenschonende Operationsmetho-de, die totale mesometriale Resektion (TMMR), von Höckel und Kollegen der Universi-tätsfrauenklinik Leipzig entwickelt. Die vorliegende retrospektive Querschnittsstudie untersucht erstmals die Auswirkungen der TMMR im Vergleich zur Wertheim-Meigs-Operation in Bezug auf die postoperative gesundheitsbezogene Lebensqualität. Dazu wurden 110 Zervixkarzinompatientinnen mit der Hilfe der Fragebögen EORTC-QLQ-C30 und EORTC-QLQ-CX24 befragt. Die Ergebnisse dieser Pilotstudie deuten daraufhin, dass Patientinnen nach einer TMMR-Operation im Vergleich zu Frauen nach einer Wert-heim-Meigs-Operation in einigen Teilaspekten eine bessere Lebensqualität haben. So fanden sich bezüglich der postoperativen körperlichen Funktionsfähigkeit und der Rol-lenfunktion sowie der postoperative Ausprägung der Symptome Fatigue, Schmerzen, Diarrhö, Appetitlosigkeit und Dyspnoe in der vorliegenden Untersuchung signifikant bessere Werte in der Gruppe der mittels TMMR operierten Frauen im Vergleich zur Wertheim-Meigs-Gruppe. Dies kann zum Anlass genommen werden große multizentri-sche prospektive Studien durchzuführen.